Strategy to Commercialize Biosimilar in European Union

This book is written precisely to develop competencies, capabilities to sail through the stormy way of commercialization of bio-similar in the most competent and competitive European market. The book gives clear cut strategy of how to enter in the EU market with all pros and corns. It also gives hypothesis for the break even along with different marketing strategies to penetrate the market. The potential five counties are studies to make the effective executable business strategy.

Info autore

Swapnil S Kalwatkar: Quality Management Specialist with over 13 years¿ of experience in Biotech and Pharmaceutical Industry.I hold a M.Pharm degree from Dr. MGR Medical University Chennai, and M.B.A from Narsee Munji Institute of Management India.

Dettagli sul prodotto

• Autori: Swapnil Kalwatkar
• Editore: LAP Lambert Academic Publishing
• Lingue: Inglese, Tedesco
• Formato: Tascabile
• Pubblicazione: 01.01.2016
• EAN: 9783659886645
• ISBN: 978-3-659-88664-5
• Pagine: 160
• Dimensioni: 150 mm x 9 mm x 220 mm
• Peso: 230 g
• Categoria: Guide e manuali > Diritto, professione, finanze > Altro